Pharmacology and the Nursing Process (Surgical Pathology: A
Case Based Approach to Diagnosis) 11th Edition | All Chapters
1-58| Latest Version| Answers With Detailed Explanations|
LATEST UPDATE A+
, TABLE OF CONTENTS
PART 1: PHARMACOLOGY BASICS ................................................................................................. 4
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY ...................................................... 4
CHAPTER 02: PHARMACOLOGIC PRINCIPLES .............................................................................. 9
CHAPTER 03: LIFESPAN CONSIDERATIONS................................................................................ 17
CHAPTER 04: CULTURAL, LEGAL, AND ETHICAL CONSIDERATIONS .......................................... 24
CHAPTER 05: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................... 31
CHAPTER 06: PATIENT EDUCATION AND DRUG THERAPY ........................................................ 35
CHAPTER 07: OVER-THE-COUNTER DRUGS AND HERBAL AND DIETARY SUPPLEMENTS ......... 40
CHAPTER 08: GENE THERAPY AND PHARMACOGENOMICS ..................................................... 45
CHAPTER 09: PHOTO ATLAS OF DRUG ADMINISTRATION ........................................................ 48
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ................................................... 59
CHAPTER 10: ANALGESIC DRUGS .............................................................................................. 59
CHAPTER 11: GENERAL AND LOCAL ANESTHETICS ................................................................... 67
CHAPTER 12: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............. 72
CHAPTER 13: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ..................... 78
CHAPTER 14: ANTIEPILEPTIC DRUGS ......................................................................................... 83
CHAPTER 15: ANTIPARKINSON DRUGS ..................................................................................... 89
CHAPTER 16: PSYCHOTHERAPEUTIC DRUGS ............................................................................. 95
CHAPTER 17: SUBSTANCE USE DISORDER............................................................................... 104
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM .......................................... 110
CHAPTER 18: ADRENERGIC DRUGS ......................................................................................... 110
CHAPTER 19: ADRENERGIC-BLOCKING DRUGS ....................................................................... 115
CHAPTER 20: CHOLINERGIC DRUGS ........................................................................................ 121
CHAPTER 21: CHOLINERGIC-BLOCKING DRUGS ...................................................................... 128
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ............................ 134
CHAPTER 22: ANTIHYPERTENSIVE DRUGS .............................................................................. 134
CHAPTER 23: ANTIANGINAL DRUGS ....................................................................................... 142
CHAPTER 24: HEART FAILURE DRUGS ..................................................................................... 148
CHAPTER 25: ANTIDYSRHYTHMIC DRUGS ............................................................................... 155
CHAPTER 26: COAGULATION MODIFIER DRUGS..................................................................... 162
, CHAPTER 27: ANTILIPEMIC DRUGS ......................................................................................... 169
CHAPTER 28: DIURETIC DRUGS ............................................................................................... 175
CHAPTER 29: FLUIDS AND ELECTROLYTES .............................................................................. 182
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS ........................ 189
CHAPTER 30: PITUITARY DRUGS ............................................................................................. 189
CHAPTER 31: THYROID AND ANTITHYROID DRUGS ................................................................ 193
CHAPTER 32: DIABETES DRUGS ............................................................................................... 199
CHAPTER 33: ADRENAL DRUGS ............................................................................................... 209
CHAPTER 34: WOMEN’S HEALTH DRUGS................................................................................ 214
CHAPTER 35: MEN’S HEALTH DRUGS ...................................................................................... 223
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM .......................................................... 229
CHAPTER 36: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ... 229
CHAPTER 37: RESPIRATORY DRUGS ........................................................................................ 235
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS ................................................... 242
CHAPTER 38: ANTIBIOTICS PART 1 .......................................................................................... 242
CHAPTER 39: ANTIBIOTICS PART 2 .......................................................................................... 250
CHAPTER 40: ANTIVIRAL DRUGS ............................................................................................. 256
CHAPTER 41: ANTITUBERCULAR DRUGS ................................................................................. 262
CHAPTER 42: ANTIFUNGAL DRUGS ......................................................................................... 268
CHAPTER 43: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ..................... 273
CHAPTER 44: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................... 279
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS ................ 286
CHAPTER 45: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC
DRUGS ..................................................................................................................................... 286
CHAPTER 46: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC DRUGS AND
MISCELLANEOUS DRUGS ......................................................................................................... 293
CHAPTER 47: BIOLOGIC RESPONSE–MODIFYING AND ANTIRHEUMATIC DRUGS .................. 299
CHAPTER 48: IMMUNOSUPPRESSANT DRUGS........................................................................ 305
CHAPTER 49: IMMUNIZING DRUGS ........................................................................................ 310
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION .................... 316
CHAPTER 50: ACID-CONTROLLING DRUGS.............................................................................. 316
, CHAPTER 51: BOWEL DISORDER DRUGS ................................................................................. 324
CHAPTER 52: ANTIEMETIC AND ANTINAUSEA DRUGS ........................................................... 333
CHAPTER 53: VITAMINS AND MINERALS ................................................................................ 339
CHAPTER 54: ANEMIA DRUGS ................................................................................................. 346
CHAPTER 55: NUTRITIONAL SUPPLEMENTS............................................................................ 354
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS .................................................. 360
CHAPTER 56: DERMATOLOGIC DRUGS ................................................................................... 360
CHAPTER 57: OPHTHALMIC DRUGS ........................................................................................ 367
CHAPTER 58: OTIC DRUGS....................................................................................................... 372
PART 1: PHARMACOLOGY BASICS
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY
MULTIPLE CHOICE
1. THE NURSE IS WRITING A NURSING DIAGNOSIS FOR A PLAN OF CARE FOR A PATIENT WHO HAS
BEEN NEWLY DIAGNOSED WITH TYPE 2 DIABETES. WHICH STATEMENT REFLECTS THE CORRECT FORMAT
FOR A NURSING DIAGNOSIS?
A. ANXIETY
B. ANXIETY RELATED TO NEW DRUG THERAPY
C. ANXIETY RELATED TO ANXIOUS FEELINGS ABOUT DRUG THERAPY, AS EVIDENCED BY
STATEMENTS SUCH AS “I’M UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”
D. ANXIETY RELATED TO NEW DRUG THERAPY, AS EVIDENCED BY STATEMENTS SUCH AS “I’M
UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”
ANS: D
FORMULATION OF NURSING DIAGNOSES IS USUALLY A THREE-STEP PROCESS. “ANXIETY” IS MISSING
THE “RELATED TO” AND “AS EVIDENCED BY” PORTIONS OF DEFINING CHARACTERISTICS. “ANXIETY
RELATED TO NEW DRUG THERAPY” IS MISSING THE “AS EVIDENCED BY” PORTION OF DEFINING
CHARACTERISTICS. THE STATEMENT BEGINNING “ANXIETY RELATED TO ANXIOUS FEELINGS” IS
INCORRECT BECAUSE THE “RELATED TO” SECTION IS SIMPLY A RESTATEMENT OF THE PROBLEM
“ANXIETY,” NOT A SEPARATE FACTOR RELATED TO THE RESPONSE.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) TOP: NURSING PROCESS: NURSING
DIAGNOSIS
Case Based Approach to Diagnosis) 11th Edition | All Chapters
1-58| Latest Version| Answers With Detailed Explanations|
LATEST UPDATE A+
, TABLE OF CONTENTS
PART 1: PHARMACOLOGY BASICS ................................................................................................. 4
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY ...................................................... 4
CHAPTER 02: PHARMACOLOGIC PRINCIPLES .............................................................................. 9
CHAPTER 03: LIFESPAN CONSIDERATIONS................................................................................ 17
CHAPTER 04: CULTURAL, LEGAL, AND ETHICAL CONSIDERATIONS .......................................... 24
CHAPTER 05: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................... 31
CHAPTER 06: PATIENT EDUCATION AND DRUG THERAPY ........................................................ 35
CHAPTER 07: OVER-THE-COUNTER DRUGS AND HERBAL AND DIETARY SUPPLEMENTS ......... 40
CHAPTER 08: GENE THERAPY AND PHARMACOGENOMICS ..................................................... 45
CHAPTER 09: PHOTO ATLAS OF DRUG ADMINISTRATION ........................................................ 48
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ................................................... 59
CHAPTER 10: ANALGESIC DRUGS .............................................................................................. 59
CHAPTER 11: GENERAL AND LOCAL ANESTHETICS ................................................................... 67
CHAPTER 12: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ............. 72
CHAPTER 13: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ..................... 78
CHAPTER 14: ANTIEPILEPTIC DRUGS ......................................................................................... 83
CHAPTER 15: ANTIPARKINSON DRUGS ..................................................................................... 89
CHAPTER 16: PSYCHOTHERAPEUTIC DRUGS ............................................................................. 95
CHAPTER 17: SUBSTANCE USE DISORDER............................................................................... 104
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM .......................................... 110
CHAPTER 18: ADRENERGIC DRUGS ......................................................................................... 110
CHAPTER 19: ADRENERGIC-BLOCKING DRUGS ....................................................................... 115
CHAPTER 20: CHOLINERGIC DRUGS ........................................................................................ 121
CHAPTER 21: CHOLINERGIC-BLOCKING DRUGS ...................................................................... 128
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ............................ 134
CHAPTER 22: ANTIHYPERTENSIVE DRUGS .............................................................................. 134
CHAPTER 23: ANTIANGINAL DRUGS ....................................................................................... 142
CHAPTER 24: HEART FAILURE DRUGS ..................................................................................... 148
CHAPTER 25: ANTIDYSRHYTHMIC DRUGS ............................................................................... 155
CHAPTER 26: COAGULATION MODIFIER DRUGS..................................................................... 162
, CHAPTER 27: ANTILIPEMIC DRUGS ......................................................................................... 169
CHAPTER 28: DIURETIC DRUGS ............................................................................................... 175
CHAPTER 29: FLUIDS AND ELECTROLYTES .............................................................................. 182
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS ........................ 189
CHAPTER 30: PITUITARY DRUGS ............................................................................................. 189
CHAPTER 31: THYROID AND ANTITHYROID DRUGS ................................................................ 193
CHAPTER 32: DIABETES DRUGS ............................................................................................... 199
CHAPTER 33: ADRENAL DRUGS ............................................................................................... 209
CHAPTER 34: WOMEN’S HEALTH DRUGS................................................................................ 214
CHAPTER 35: MEN’S HEALTH DRUGS ...................................................................................... 223
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM .......................................................... 229
CHAPTER 36: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ... 229
CHAPTER 37: RESPIRATORY DRUGS ........................................................................................ 235
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS ................................................... 242
CHAPTER 38: ANTIBIOTICS PART 1 .......................................................................................... 242
CHAPTER 39: ANTIBIOTICS PART 2 .......................................................................................... 250
CHAPTER 40: ANTIVIRAL DRUGS ............................................................................................. 256
CHAPTER 41: ANTITUBERCULAR DRUGS ................................................................................. 262
CHAPTER 42: ANTIFUNGAL DRUGS ......................................................................................... 268
CHAPTER 43: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ..................... 273
CHAPTER 44: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................... 279
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS ................ 286
CHAPTER 45: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC
DRUGS ..................................................................................................................................... 286
CHAPTER 46: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC DRUGS AND
MISCELLANEOUS DRUGS ......................................................................................................... 293
CHAPTER 47: BIOLOGIC RESPONSE–MODIFYING AND ANTIRHEUMATIC DRUGS .................. 299
CHAPTER 48: IMMUNOSUPPRESSANT DRUGS........................................................................ 305
CHAPTER 49: IMMUNIZING DRUGS ........................................................................................ 310
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION .................... 316
CHAPTER 50: ACID-CONTROLLING DRUGS.............................................................................. 316
, CHAPTER 51: BOWEL DISORDER DRUGS ................................................................................. 324
CHAPTER 52: ANTIEMETIC AND ANTINAUSEA DRUGS ........................................................... 333
CHAPTER 53: VITAMINS AND MINERALS ................................................................................ 339
CHAPTER 54: ANEMIA DRUGS ................................................................................................. 346
CHAPTER 55: NUTRITIONAL SUPPLEMENTS............................................................................ 354
PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS .................................................. 360
CHAPTER 56: DERMATOLOGIC DRUGS ................................................................................... 360
CHAPTER 57: OPHTHALMIC DRUGS ........................................................................................ 367
CHAPTER 58: OTIC DRUGS....................................................................................................... 372
PART 1: PHARMACOLOGY BASICS
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY
MULTIPLE CHOICE
1. THE NURSE IS WRITING A NURSING DIAGNOSIS FOR A PLAN OF CARE FOR A PATIENT WHO HAS
BEEN NEWLY DIAGNOSED WITH TYPE 2 DIABETES. WHICH STATEMENT REFLECTS THE CORRECT FORMAT
FOR A NURSING DIAGNOSIS?
A. ANXIETY
B. ANXIETY RELATED TO NEW DRUG THERAPY
C. ANXIETY RELATED TO ANXIOUS FEELINGS ABOUT DRUG THERAPY, AS EVIDENCED BY
STATEMENTS SUCH AS “I’M UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”
D. ANXIETY RELATED TO NEW DRUG THERAPY, AS EVIDENCED BY STATEMENTS SUCH AS “I’M
UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”
ANS: D
FORMULATION OF NURSING DIAGNOSES IS USUALLY A THREE-STEP PROCESS. “ANXIETY” IS MISSING
THE “RELATED TO” AND “AS EVIDENCED BY” PORTIONS OF DEFINING CHARACTERISTICS. “ANXIETY
RELATED TO NEW DRUG THERAPY” IS MISSING THE “AS EVIDENCED BY” PORTION OF DEFINING
CHARACTERISTICS. THE STATEMENT BEGINNING “ANXIETY RELATED TO ANXIOUS FEELINGS” IS
INCORRECT BECAUSE THE “RELATED TO” SECTION IS SIMPLY A RESTATEMENT OF THE PROBLEM
“ANXIETY,” NOT A SEPARATE FACTOR RELATED TO THE RESPONSE.
DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) TOP: NURSING PROCESS: NURSING
DIAGNOSIS
